Prescription Drugs Covered under Medicare Part B Scrutinized as Part of ICER’s Annual Unsupported Price Increase (UPI) Report
As anticipated, the drug pricing watchdog group, the Institute for Clinical and Economic Review (ICER), published its fourth annual Unsupported Price Increase (UPI) Report on prescription drugs in the United States.